Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • 5-HT Receptor
    (1)
  • ADC Cytotoxin
    (1)
  • Androgen Receptor
    (1)
  • Drug-Linker Conjugates for ADC
    (1)
  • Estrogen Receptor/ERR
    (1)
  • HER
    (1)
  • Opioid Receptor
    (1)
  • Sigma receptor
    (1)
  • iGluR
    (1)
  • Others
    (18)
Filter
Search Result
Results for "

target/Adrenergic_Receptor/3

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    31
    TargetMol | Activity
  • Compound Libraries
    1
    TargetMol | inventory
  • Peptide Products
    2
    TargetMol | natural
AMPA receptor antagonist-3
T61813923272-18-8
AMPA receptor antagonist-3 is an AMPA receptor antagonist.
  • $195
In Stock
Size
QTY
Sigma-1 receptor antagonist 3
T129121639220-17-9In house
Sigma-1 receptor antagonist 3 is a potent and selective antagonist of Sigma-1 (σ1) receptor(Ki : 1.14 nM), has the potential for the neuropathic pain.
  • $81
In Stock
Size
QTY
TargetMol | Inhibitor Sale
GPR34 receptor antagonist 3
T82264
Compound 5e, a GPR34 receptor antagonist, exhibits selective inhibition of lysophosphatidylserine-induced ERK1 2 phosphorylation in a dose-dependent manner, demonstrating an IC50 value of 0.680 μM without significant cytotoxicity. Additionally, it displays antisensory activity in a mouse neuropathic pain model [1].
  • Inquiry Price
Size
QTY
Adenosine receptor antagonist 3
T608722400864-80-2
Adenosine receptor antagonist 3 has the potential for cancer disease research which is a potent adenosine receptor antagonist [1].
  • $954
6-8 weeks
Size
QTY
Mu opioid receptor antagonist 3
T62767
Mu opioid receptor antagonist 3 (compound 26) is a potent and selective MOR antagonist with the ability to penetrate the blood-brain barrier (Ki: 0.24 nM, EC50: 0.54 nM). This compound can be used to study opioid use disorder (OUD).
  • $1,520
10-14 weeks
Size
QTY
TGR5 Receptor Agonist 3
T635542643391-08-4
TGR5 Receptor Agonist 3 is a G protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonist soft drug compound that decreases gallbladder filling, exhibits good gallbladder safety, and is able to act on hTGR5 (EC50: 16.4 nM) and mTGR5 (EC50: 209 nM).
  • $1,520
10-14 weeks
Size
QTY
Androgen receptor antagonist 3
T60987353484-46-5
Androgen receptor antagonist 3 (Compound C18) exhibits anticancer activity as an antagonist of the androgen receptor (AR) with an IC50 value of 2.4 μM [1].
  • $2,140
6-8 weeks
Size
QTY
NMDA receptor modulator 3
T606852758256-02-7
NMDA receptor modulator 3 (Compound 99) is a potent NMDA receptor modulator useful in neurological disorder research [1].
  • $1,520
6-8 weeks
Size
QTY
Estrogen receptor antagonist 3
T639142730011-50-2
Estrogen receptor antagonist 3 is a potent degradation agent of the estrogen receptor (ER). Estrogen signaling systems regulate cell growth, differentiation, and apoptosis, and estrogen receptor antagonist 4 has shown potential for cancer research.
  • $2,140
8-10 weeks
Size
QTY
GLP-1 receptor agonist 3
T114042230200-09-4
GLP-1 receptor agonist 3 is a GLP-1 receptor agonist,Example 4A-1, has EC50s of 1.1 nM and 13 nM in Clone H6 and Clone C6 cell lines assay, respectively.
  • $1,820
8-10 weeks
Size
QTY
GABAA receptor modular-3
T887173021554-08-2
Compound S28, also known as GABAA receptor modulator-3, regulates the (γ-aminobutyric acid)A receptor (GABAA receptor), exhibiting EC50 values of 56 nM for the α1β2γ2 subtype and 10 nM for the α4β3δ subtype. In rats, it demonstrates favorable pharmacokinetic properties and slight toxicity. The threshold dose for loss of righting reflex (LORR) in rats is 23.3 μmol kg. Furthermore, Compound S28 shows potential to alleviate postpartum depression.
  • Inquiry Price
10-14 weeks
Size
QTY
Androgen receptor degrader-3
T798912753650-84-7
Androgen Receptor Degrader-3 (ARD-3) is a compound that inhibits androgen receptor signaling and promotes the degradation of the receptor, with potential applications in prostate cancer research [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Orexin receptor antagonist 3
T624531293282-55-9
Orexin receptor antagonist 3 (example 216) functions as an orexin receptor antagonist.
  • $1,620
6-8 weeks
Size
QTY
A2A receptor antagonist 3
T627972738606-83-0
A2A receptor antagonist 3 (Example 92) is an adenosine A2A receptor antagonist (Ki: 0.4 nM) and a receptor (Ki: 1467 nM).
  • $2,140
6-8 weeks
Size
QTY
Protease-Activated Receptor-1 antagonist 3
T63382
Protease-Activated Receptor-1 antagonist 3 is a potent antagonist of Protease-Activated Receptor-1 (IC50: 7 nM) and exhibits binding affinity to hERG K+ channels (IC50: 9 μM).
  • $1,520
10-14 weeks
Size
QTY
CB2 receptor agonist 3
T24097919077-81-9
GP 2A is a selective agonist of CB2 receptor.
  • $767
6-8 weeks
Size
QTY
NMDA receptor antagonist-3
T60792
NMDA receptor antagonist-3 is a NMDA receptor antagonist with a significan recovery rate (40.0%, at 100 μM) and safe toxicological characteristics in SH-SY5Y and human adipose mesenchymal stem cells.
  • $1,520
10-14 weeks
Size
QTY
Protease-Activated Receptor-3 (PAR-3) (1-6), human
T362861872435-09-0
TFRGAP-amide, human PAR-3-derived tethered ligand sequence which does not activate PAR-3 but rather activates PAR-1 and PAR-2, either in Jurkat or in other PAR-expressing cells.
  • $580
35 days
Size
QTY
Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA
T36289
Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA, is a peptide that acts as an agonist for the proteinase-activated receptor (PAR-3) [1].
  • $83
Backorder
Size
QTY
ET receptor antagonist 3
T79575
ET receptor antagonist 3 (compound 17d) is an orally active ET receptor antagonist with an IC50 of 0.26 nM, utilized for pulmonary arterial hypertension (PAH) research. This compound demonstrates efficacy in mitigating monocrotaline-induced PAH in a rat model [1].
  • Inquiry Price
Size
QTY
RXFP1 receptor agonist-3
T812442924767-53-1
RXFP1 receptor agonist-3 (Example 223) is an RXFP1 receptor agonist that inhibits cyclic AMP (cAMP) production in HEK293 cells stably expressing human RXFP1, with an EC50 of 2 nM [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Glucagon receptor antagonists-3
T11415202917-17-7
Glucagon receptor antagonist -3 is a highly effective glucagon receptor antagonist.
  • $755
8-10 weeks
Size
QTY
P2X7 receptor antagonist-3
T721981627900-92-8
P2X7 receptor antagonist-3 is a potent inhibitor of the P2X7 receptor, with IC50 values of 4.2 nM in humans and 6.8 nM in rats, demonstrating its high efficacy across species.
  • $1,520
6-8 weeks
Size
QTY
GABAB receptor antagonist 3
T86484160415-40-7
3 (example 3) acts as an antagonist to the GABAB receptor [1].
  • Inquiry Price
10-14 weeks
Size
QTY
EP4 receptor antagonist 3
T385951207954-34-4
EP4 receptor antagonist 3 is a highly potent and specific inhibitor of the EP4 receptor, intended for research purposes in studying EP4 receptor-mediated diseases, including acute and chronic pain, osteoarthritis, rheumatoid arthritis, and cancer.
  • $970
Backorder
Size
QTY
5-HT2A receptor agonist-3
T791551391499-52-7
5-HT2A receptor agonist-3 represents the highest selectivity for the human 5-HT2A receptor currently identified, exhibiting a K i of 2.5 nM. It also demonstrates a remarkable 124-fold selectivity over its structurally analogous 5-HT2C receptor [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Glucocorticoid receptor agonist-3
T877032842165-73-3
Glucocorticoid Receptor Agonist-3 (Preparation 6) acts as a glucocorticoid receptor agonist [1].
  • Inquiry Price
10-14 weeks
Size
QTY
Glucocorticoid receptor modulator 3
T885842688785-13-7
Glucocorticoid receptor modulator3 (Payload 6) is a thioester-based modulator of the glucocorticoid receptor, exhibiting a potent IC50 value of 0.6 nM. This compound is deactivated through rapid hepatic metabolism, minimizing systemic exposure of its unconjugated active payload. Glucocorticoid receptor modulator3 is suitable for development in antibody-drug conjugates (ADCs) targeted at autoimmune diseases.
  • Inquiry Price
10-14 weeks
Size
QTY
μ opioid receptor agonist 3
T794302378397-91-0
Compound 20, identified as μ opioid receptor agonist 3, is a potent µOR agonist that exhibits an EC50 value of 0.87 nM. It holds promise for research into pain management and neuropsychiatric disorders [1].
  • $1,520
8-10 weeks
Size
QTY
APJ receptor agonist 3
T635482759159-56-1
APJ receptor agonist 3 is a highly effective, orally administrable APJ receptor agonist, with a potent EC50 value of 0.027 nM.
  • $1,520
10-14 weeks
Size
QTY
Glucocorticoid receptor agonist-3 Ala-Ala-Mal
T878493014393-35-9
Glucocorticoid Receptor Agonist-3 Ala-Ala-Mal (Compound Preparation 8) is a conjugate of an anti-human TNFα antibody and a glucocorticoid receptor agonist (GC). It is utilized in researching autoimmune and inflammatory diseases [1].
  • Inquiry Price
Inquiry
Size
QTY